BETHANY LAMAR: Open Payments
NPI 1467494914 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 16 payments from 10 companies in 2025. Trend: 2023 $264 · 2024 $371 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 3 | $71 |
| SANOFI-AVENTIS U.S. LLC | 3 | $69 |
| ABBVIE INC. | 3 | $48 |
| Lilly USA, LLC | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Insulet Corporation | 1 | $21 |
| Mannkind Corporation | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Insmed, Inc. | 1 | $17 |
| Medtronic, Inc. | 1 | $15 |
Products named: RECORLEV, TZIELD, UBRELVY, MOUNJARO, Korlym, Omnipod, AFREZZA, Kerendia.
Industry payments across AL — which companies pay providers there.
